Evaluation of Hematological and Biochemical Parameters that Predict the No-reflow Phenomenon in Patients Undergoing Primary Percutaneous Coronary Intervention

被引:0
|
作者
Aydemir, Selim [1 ]
Aydin, Sidar Siyar [2 ]
Altinkaya, Onur [1 ]
Aksakal, Emrah [1 ]
Ozmen, Murat [1 ]
机构
[1] Univ Hlth Sci, Erzurum City Hosp, Dept Cardiol, TR-25080 Erzurum, Turkiye
[2] Ataturk Univ, Fac Med, Dept Cardiol, Erzurum, Turkiye
关键词
acute coronary syndrome; no-reflow phenomenon; primary percutaneous coronary intervention; ELEVATION MYOCARDIAL-INFARCTION; TO-LYMPHOCYTE RATIO; CELL DISTRIBUTION WIDTH; ADVERSE CARDIAC EVENTS; LONG-TERM OUTCOMES; MICROVASCULAR OBSTRUCTION; NEUTROPHIL/LYMPHOCYTE RATIO; D-DIMER; NEUTROPHIL; MORTALITY;
D O I
10.1177/00033197251320141
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Acute coronary syndromes (ACS) are one of the most common causes of morbidity and mortality worldwide. Primary percutaneous coronary intervention (pPCI) is the main treatment strategy to restore myocardial perfusion. However, the no-reflow phenomenon (NRP) may block coronary flow. The present study focused on assessing and contrasting predictive parameters for NRP in ACS patients. Our research is a retrospective analysis. We assessed the parameters significantly associated with NRP using Cox regression and Receiver operating characteristic (ROC) Curve analysis. The study included 5122 patients who met the criteria. The average age of the patients was 63.9 + 13.2, and 74.4% were male. It was observed that NRP developed in 1.8% of all patients. Age, hemoglobin (Hb), white blood cell (WBC), glucose and low density lipoprotein cholesterol (LDL-C) were determined to be independent predictors of NRP. The power of these parameters to predict NRP was similar, and WBC was the most predictive (Area Under Curve (AUC): 0.605 95% CI: 0.539-0.671, P = .001). We believe that the use of these simple, practical, and routinely used hematological and biochemical parameters will help us predict the risk of developing NRP before pPCI. This information should improve management.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Factors influencing no-reflow phenomenon in patients with ST-segment myocardial infarction treated with primary percutaneous coronary intervention
    Dzudovic, B.
    Djenic, N.
    Romanovic, R.
    Obradovic, S.
    EUROPEAN HEART JOURNAL, 2015, 36 : 141 - 141
  • [42] A NEW SCORE FOR PREDICTION OF SLOW/NO-REFLOW PHENOMENON DURING PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
    Bakr, Mohamed Abo
    Roshdy, Hisham Samir
    Elawadi, Mohamed Ibrahim Mostafa
    Elshaer, Mohamed Hossam Eldein
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 105 - 105
  • [43] Relationship between circulating miRNA-30e and no-reflow phenomenon in STEMI patients undergoing primary coronary intervention
    Su, Qiang
    Ye, Ziliang
    Sun, Yuhan
    Yang, Huafeng
    Li, Lang
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2018, 78 (04): : 318 - 324
  • [44] Systemic immune-inflammation index predicts no-reflow phenomenon after primary percutaneous coronary intervention
    Esenboga, Kerim
    Kurtul, Alparslan
    Yamanturk, Yakup Yunus
    Tan, Turkan Seda
    Tutar, Durmus Eralp
    ACTA CARDIOLOGICA, 2022, 77 (01) : 59 - 65
  • [45] The assessment of no-reflow phenomenon incidence in early versus delayed percutaneous coronary intervention following a primary fibrinolysis
    Amirpour, Afshin
    Behjati, Mohammad Amin
    Zavar, Reihane
    Shirvani, Ehsan
    Zarepour, Ehsan
    Hassannejad, Razieh
    Sadeghi, Masoumeh
    Poodeh, Raheleh Janghorbanian
    Safaei, Ali
    Sanaei, Shahin
    Mahinparva, Nazanin
    ARYA ATHEROSCLEROSIS, 2024, 20 (02)
  • [46] Feasibility of lymphocyte-to-monocyte ratio in predicting no-reflow phenomenon in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention
    郑宝娟
    马墩亮
    卓胜青
    田相亭
    South China Journal of Cardiology, 2019, 20 (04) : 228 - 235
  • [47] The SALINE Technique for the Treatment of the No-Reflow Phenomenon during Percutaneous Coronary Intervention in STEMI
    Grancini, Luca
    Diana, Davide
    Centola, Alice
    Monizzi, Giovanni
    Mastrangelo, Angelo
    Olivares, Paolo
    Montorsi, Piero
    Alushi, Brunilda
    Bartorelli, Antonio L.
    Galassi, Alfredo R.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (06)
  • [48] Predicting the no-reflow phenomenon in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: a systematic review of clinical prediction models
    Ebrahimi, Reza
    Rahmani, Mahdi
    Fallahtafti, Parisa
    Ghaseminejad-Raeini, Amirhossein
    Azarboo, Alireza
    Jalali, Arash
    Mehrani, Mehdi
    THERAPEUTIC ADVANCES IN CARDIOVASCULAR DISEASE, 2024, 18
  • [49] The impact of lesion complexity on no-reflow phenomenon and predictors of reversibility in patients treated with primary percutaneous intervention
    Durmaz, Eser
    Karadag, Bilgehan
    Ikitimur, Baris
    Atici, Adem
    Koca, Damla
    Mutlu, Deniz
    Soysal, Ali Ugur
    Raimoglu, Utku
    Ozmen, Emre
    Ohtaroglu Tokdil, Kardelen
    Incesu, Gunduz
    Ongen, Zeki
    CORONARY ARTERY DISEASE, 2020, 31 (08) : 678 - 686
  • [50] Predictive Factors and Protective Factors after Primary Percutaneous Coronary Intervention in Patients with No-reflow
    Mo, F. R.
    Li, J.
    Cu, L. X.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015, 63 : S337 - S337